comparemela.com

Latest Breaking News On - பல்கலைக்கழகம் பள்ளி ஆஃப் வேதியியல் - Page 1 : comparemela.com

BioCaptiva bids to revolutionise cancer care in Scotland

Why are you making commenting on The National only available to subscribers? We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions. What should we do with our second vote in 2021? What happens if Westminster says no to indyref2? Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversation, register under fake names, and post vile abuse. We’ve had hundreds of emails from you complaining about this, asking us to take steps to ensure that these people aren’t given a platform on our site.

Scottish spinout in £1m raise to fund cancer test breakthrough

By Victoria Masterson A SPIN-OUT from the University of Edinburgh has raised £1 million to develop a new device that could “revolutionise” the early diagnosis and monitoring of difficult to detect cancers, such as kidney, thyroid and brain cancer. BioCaptiva raised the seed investment from business angel syndicate, Archangels, and economic development agency Scottish Enterprise for its ‘BioCollector’ device. The company says this overcomes “significant limitations” of current liquid biopsy testing – where blood is analysed for cells from cancerous tumours. “We are confident that this platform technology can make a significant impact in this important area and, ultimately, enable cancers to be detected more quickly and accurately, enabling patients to receive precision cancer treatment as early as possible,” said BioCaptiva chief executive Jeremy Wheeler.

COVID-19: A new more accurate test with results in less than 5 minutes – Ya Libnan

Share: A new COVID-19 test that reduces testing time from 30 minutes to less than five and delivers accurate results has been developed by researchers at the University of Birmingham. The researchers believe their method could deliver a test that is not only fast but also sufficiently sensitive. The test does not require samples to be treated at high temperatures, and it can be performed using standard laboratory equipment, making it readily deployable. A preprint paper (yet to be peer reviewed) describing the new process has been published on MedRxiv in which the researchers demonstrate the rapidity and sensitivity of their method using patient sample RNA provided by Public Health England.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.